June 29, 2022, from Shenzhen, GuangdongBarley hair transplant Medical (Shenzhen) Group Co., Ltd.Barley Hair Transplant Medical (Shenzhen) Group Co., Ltd. (abbreviated as "Barley hair transplantSubmit a prospectus on the Hong Kong Stock Exchange with a view to issuing H-shares on the Hong Kong main board.
Barley hair transplant prospectus link:
Https://www1.hkexnews.hk/app/sehk/2022/104548/documents/sehk22062902313_c.pdf
Main businessBarley hair transplantAs a leading medical group in the middle and high-end hair diagnosis and treatment service industry in China, it provides full-cycle hair diagnosis and treatment services to patients mainly through consultation, diagnosis, microneedle hair implantation, hair fixation and hair maintenance.
According to the Burning knowledge Consulting report, based on 2021 incomeBarley hair transplantIt is the largest medical group providing hair diagnosis and treatment services in China's first-tier cities, with a market share of 5.2%.
According to the burning knowledge consultation reportBarley hair transplantIt is the first medical group in China to provide full-cycle hair diagnosis and treatment services including consultation and diagnosis, microneedle hair implantation, hair fixation and hair care. As of the last practical date, the company has 180 registered doctors and 690 other medical professionals with relevant medical background and rich experience in hair diagnosis and treatment.
Shareholder structure
The prospectus showsBarley hair transplantIn the pre-IPO shareholder structure
Dr. Li Xingdong, 15.00% shareholding
Mr. Li Jilin (father of Dr. Li Xingdong), holding 5.00%
Hainan Kefayuan, holding 65.00%; (Hainan Kefayuan Investment, Ms. Cui Shaofang (the spouse of Dr. Li Xingdong) holds 70% and 30% respectively; while the shareholders of Sikangyuan Investment are Dr. Li Xingdong (90%) and Mr. Li Jilin (10%).
Employee incentive platformNingbo Science and Technology Super(Li Xingdong and Li Jilin hold 6% and 74% respectively, while 33 other employees hold 20% partnership interest), holding 4.00%; employee incentive platformNingbo Keying(Li Xingdong and Li Jilin hold 0.27% and 63.04% respectively, while 24 other employees hold 36.69% partnership interest), holding 3.00%
Dr. Li Xingdong, Ms. Cui Shaofang, Mr. Li Jilin, Hainan Kefayuan, Sikangyuan Investment, Ningbo Keying and Ningbo Kechao together hold approximately 92.00% of the voting rights of the Company, which is the controlling shareholder group of the Company.
Ningbo Ketuo(Ms. Pan Yang holds 55.56% partnership interest through Hainan Runhui, Dr. Li Xingdong and Ms. Cui Shaofang hold 32.04% partnership interest, Ms. Cui Shaoyan (company employee and sister of Ms. Cui Shaofang) holds 5.00% partnership interest, Ms. Wang Yanpu holds 2.47% partnership interest, Ms. Wang Pengying holds 4.94% partnership interest, and holds 2.70%.
Lishui ZhongruiHold 4.30% of the shares
Shanghai Nuowiqi, holding 1.00%.
Company performance
According to the prospectus, in the past three fiscal years, 2019, 2020 and 2021Barley hair transplantThe operating income was 747 million, 764 million and 1.021 billion yuan respectively, and the corresponding net profit was-15.014 million, 69.558 million and 66.116 million yuan respectively.
Intermediary teamBarley hair transplantThe intermediary teams of this IPO mainly include: Citic Construction Investment International as its exclusive sponsor; Ernst & Young as its auditor; Shanghai Guangfa and Gao Weisheng as their company's Chinese lawyers and Hong Kong lawyers respectively; Jingtian Gongcheng and Jingtian Gongcheng (Hong Kong) as their securities firms' Chinese lawyers and Hong Kong lawyers respectively; and Fuji Consulting as its independent industry consultant.
Copyright notice: all original articles of Ryan Capital Ryanben Capital must be reproduced by contacting authorization and indicating the source, author and Wechat ID at the beginning / end of the article, otherwise Ryan will pursue legal liability against it. When some articles were pushed, they could not contact the original author or the official account platform. If copyright issues are involved, please contact us with the original author.More information on the listing of Hong Kong IPO:Www.ryanbencapital.com
Related reading
Yonghe Medical, which is about to list IPO in Hong Kong through the hearing of the Hong Kong Stock Exchange, is expected to become the "first share of hair transplant".Hong Kong IPO rejected case: a medical company "business heavily dependent on a single doctor", listing was rejected by the Hong Kong Stock Exchange
Hong Kong IPO rejected case: a medical company "business performance continues to decline, can not prove business improvement", the listing application was rejected by the Hong Kong Stock ExchangeRanking of Hong Kong IPO intermediaries (past 24 months: June 2020 to May 2022)